← Return to New peripheral neuropathy drug gets FDA advance

Discussion
proteusx avatar

New peripheral neuropathy drug gets FDA advance

Neuropathy | Last Active: Jan 26, 2025 | Replies (19)
Comment receiving replies
Profile picture for Mary Ann @crissma

This medication is approved for short term pain not neuropathy

Jump to this post

Replies to "This medication is approved for short term pain not neuropathy"
John, Volunteer Mentor | @johnbishop | Jun 23, 2025

Actually, it's also being looked at to treat neuropathy but you are correct about the short term pain usage.
-- Suzetrigine, a Selective Pain Signal Inhibitor of NaV1.8 Shows Proof-of-concept for Treatment of Painful Diabetic Peripheral Neuropathy: https://www.neurology.org/doi/10.1212/WNL.0000000000210760

VIEW AND REPLY